The global Medical Device Contract Manufacturing Market, valued at US$78.58 billion in 2024, stood at US$83.77 billion in ...

The global In-Vitro Diagnostics (IVDs) Medical Device Market was valued at approximately USD 86 billion in 2024 and is projected to reach USD 135 billion by 2034, growing at a CAGR of 4.8% over ...

Known IVD devices can read lateral flow assay strips to detect the existence of a hormone, metabolite, toxin, or pathogen-derived antigen.

About Clarvin To medical device and IVD manufacturers, Clarvin is the regulatory consultant that guides and supports in every aspect of regulatory affairs and quality assurance processes.

The report provides the revenue of the global medical device & IVD regulatory affairs outsourcing market for the period 2018-2030, considering 2019 as the base year and 2030 as the forecast year.

The FDA’s new guidance document on informed consent for IVD studies using leftover human specimens will positively impact industry with regards to facilitating the development of new technologies.

The Global IVD Contract Manufacturing Services Market valued at $4.6 billion (2021) is set to witness a growth rate of 4% by 2026. Growing preference for point-of-care (POC) testing services, Covid-19 ...

Insurers label the devices “experimental” and “unproven,” and refuse to reimburse for their use. So what can IVD and digital health companies do to improve their odds for reimbursement?